IL19 and breast carcinoma: We also found that the expression level of IL20RA ligands IL-19, IL-20, and IL-24 was dramatically elevated in the serum of breast cancer patients compared to that of healthy donors, indicating that IL20RA signaling may play an important role in the progression of cancer.